Oncotarget

Research Papers:

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2

Yan-Li Li, Ju Wang, Cai-Yan Zhang, Yu-Qing Shen, Hui-Min Wang, Lei Ding, Yu-Chen Gu, Jia-Tao Lou, Xin-Tai Zhao, Zhong-Liang Ma and You-Xin Jin _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:59287-59298. https://doi.org/10.18632/oncotarget.11040

Metrics: PDF 2343 views  |   HTML 2569 views  |   ?  


Abstract

Yan-Li Li1,*, Ju Wang1,*, Cai-Yan Zhang1,*, Yu-Qing Shen1, Hui-Min Wang1, Lei Ding1, Yu-Chen Gu1, Jia-Tao Lou2, Xin-Tai Zhao3, Zhong-Liang Ma1, You-Xin Jin1

1School of Life Sciences, Shanghai University, Shanghai 200444, China

2Department of Laboratory Medicine, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200030, China

3Shanghai Shines Pharmaceuticals Co., Ltd., Shanghai 200032, China

*These authors contributed equally to this work

Correspondence to:

You-Xin Jin, email: jinyouxin@shu.edu.cn

Zhong-Liang Ma, email: zlma@shu.edu.cn

Keywords: miR-146a-5p, non-small cell lung cancer, tumor suppressor gene, cell cycle, CCND1

Received: March 02, 2016     Accepted: June 03, 2016     Published: August 03, 2016

ABSTRACT

Previous studies have indicated that miR-146a-5p acts as an oncogene in several types of cancer, yet a tumor suppressor gene in others. In non-small cell lung cancer (NSCLC), one report showed that it was downregulated and played the role of tumor suppressor. However, another study showed that miR-146a-5p was overexpressed in the serum of NSCLC patients compared to healthy controls. Therefore, it is obvious that further study of the function of miR-146a-5p in NSCLC is necessary to fully understand its importance. Herein, we have verified that miR- 146a- 5p acts as a tumor suppressor in NSCLC. Our data revealed that the expression level of miR-146a-5p was significantly decreased in several human NSCLC cell lines, and also less abundant in human NSCLC tissues, when compared with controls. Moreover, we observed that miR-146a-5p could suppress cell proliferation, both in vitro and in vivo. Our results also showed that miR-146a-5p directly targeted the 3′-UTR of CCND1 and CCND2 mRNAs as well as decreased their expression at both mRNA and protein levels, causing cell cycle arrest at the G0/G1 phase. Furthermore, siRNA-mediated downregulation of CCND1 or CCND2 yielded the same effects on proliferation and cell cycle arrest as miR-146a-5p upregulation did in the NSCLC cell lines. We confirmed that the expression of miR-146a-5p had negative relationship with CCND1 or CCND2. Besides, we also found that miR-146a-5p could inhibit tumor growth in xenograft mouse models, and CCND1 and CCND2 were downregulated in miR-146a-5p overexpressed xenograft tumor tissues. In summary, our results demonstrated that miR-146a-5p could suppress the proliferation and cell cycle progression in NSCLC cells by inhibiting the expression of CCND1 and CCND2.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11040